|
ZCCHC4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.730000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.559100E-04 |
| Normal-vs-Stage2 |
6.289500E-02 |
| Normal-vs-Stage3 |
3.391000E-01 |
| Normal-vs-Stage4 |
5.463600E-01 |
| Stage1-vs-Stage2 |
8.292200E-01 |
| Stage1-vs-Stage3 |
2.16419999999884E-05 |
| Stage1-vs-Stage4 |
1.978300E-04 |
| Stage2-vs-Stage3 |
1.681830E-02 |
| Stage2-vs-Stage4 |
3.198100E-02 |
| Stage3-vs-Stage4 |
7.945800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.271600E-02 |
| Normal-vs-AfricanAmerican |
6.514600E-01 |
| Normal-vs-Asian |
1.777610E-01 |
| Caucasian-vs-AfricanAmerican |
6.586300E-02 |
| Caucasian-vs-Asian |
2.490000E-01 |
| AfricanAmerican-vs-Asian |
5.828300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.608000E-02 |
| Normal-vs-Female |
2.055000E-01 |
| Male-vs-Female |
4.071800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.266200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.124000E-02 |
| Normal-vs-Age(61-80Yrs) |
7.330300E-02 |
| Normal-vs-Age(81-100Yrs) |
7.566600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.044400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.882200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.323800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.304600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.954980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.688000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.842720E-03 |
| Normal-vs-Grade 2 |
5.187700E-04 |
| Normal-vs-Grade 3 |
3.759600E-01 |
| Normal-vs-Grade 4 |
8.035800E-02 |
| Grade 1-vs-Grade 2 |
4.049600E-01 |
| Grade 1-vs-Grade 3 |
4.938200E-02 |
| Grade 1-vs-Grade 4 |
2.222100E-03 |
| Grade 2-vs-Grade 3 |
5.781200E-03 |
| Grade 2-vs-Grade 4 |
2.37669999999524E-05 |
| Grade 3-vs-Grade 4 |
1.378460E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.99729999989162E-07 |
| Normal-vs-ccB subtype |
9.982000E-01 |
| ccA subtype-vs-ccB subtype |
2.99710000040143E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.253500E-02 |
| Normal-vs-N1 |
8.361200E-01 |
| N0-vs-N1 |
3.047600E-01 |
|
|
